Sisram Medical Ltd
SRAMF
$0.5512
$0.000.00%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -20.23% | -30.41% | -38.74% | -29.98% | -21.59% |
| Total Depreciation and Amortization | 21.57% | 29.51% | 38.80% | 26.67% | 14.78% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -92.97% | -55.47% | -36.39% | -44.70% | -52.46% |
| Change in Net Operating Assets | -40.93% | 65.52% | 83.30% | 83.30% | 83.30% |
| Cash from Operations | -24.70% | 15.29% | 106.05% | 102.49% | 99.36% |
| Capital Expenditure | 67.92% | 37.65% | -2.58% | -35.54% | -80.23% |
| Sale of Property, Plant, and Equipment | -8.33% | 2,433.33% | 822.22% | 148.39% | -70.00% |
| Cash Acquisitions | 94.53% | 88.69% | 81.80% | -36.40% | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -126.90% | 123.08% | 123.66% | 120.16% | 116.42% |
| Cash from Investing | 80.01% | 94.77% | 100.54% | 76.15% | 36.69% |
| Total Debt Issued | 70.33% | 37.69% | 8.47% | -9.57% | -24.74% |
| Total Debt Repaid | -22.85% | -18.33% | -13.33% | -4.88% | 2.57% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | 10.09% | -0.63% | -12.71% | -12.71% | -12.71% |
| Other Financing Activities | 102.81% | 79.14% | 62.27% | 29.25% | -31.83% |
| Cash from Financing | 23.14% | 13.65% | 3.43% | -6.58% | -17.48% |
| Foreign Exchange rate Adjustments | 80.96% | 49.57% | 16.57% | -21.82% | -91.89% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 167.10% | 127.06% | 120.60% | 102.85% | 71.56% |